News + Filings Transactions
|
Yale Catriona
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/13/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 591 | $55.16 | $32.6k | | 06/13/2023 |
03/10/2023 | Akero Therapeutics, Inc. | AKRO | Payment of Exercise | Common Stock | 701 | $43.46 | $30.5k | | 03/10/2023 |
01/13/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 1k | $49.12 | $51.5k | | 01/13/2023 |
01/13/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 1.5k | $49.89 | $76.5k | | 01/13/2023 |
01/13/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 1.3k | $51.18 | $67.2k | | 01/13/2023 |
01/13/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 1.1k | $51.99 | $57.4k | | 01/13/2023 |
12/16/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 29.1k | $21.10 | $613.4k | | 12/16/2022 |
12/12/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 4.6k | $43.18 | $198.5k | | 12/09/2022 |
12/12/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 402 | $43.77 | $17.6k | | 12/09/2022 |
12/09/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 86.4k | $42.95 | $3.7M | | 12/09/2022 |
12/09/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Common Stock | 19.2k | $0.00 | $0 | | 12/09/2022 |
11/10/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 100 | $39.96 | $4k | | 11/10/2022 |
11/10/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 4.9k | $39.41 | $193.1k | | 11/10/2022 |
10/10/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 5k | $37.99 | $190k | | 10/10/2022 |
09/13/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 14k | $28.04 | $392.2k | | 09/13/2022 |
09/13/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 29.1k | $21.10 | $613.5k | | 09/09/2022 |
09/13/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 26k | $27.18 | $707.1k | | 09/13/2022 |
09/09/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 29.1k | $21.10 | $613.5k | | 09/09/2022 |
06/30/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Common Stock | 1.2k | $8.03 | $9.3k | | 09/09/2022 |
12/08/2021 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 87.2k | $21.10 | $1.8M | | 12/08/2021 |
10/15/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 100 | $22.34 | $2.2k | | 10/15/2021 |
10/15/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 12.4k | $21.58 | $267.6k | | 10/15/2021 |
09/15/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 2k | $25.31 | $50.6k | | 09/15/2021 |
09/15/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 10.5k | $24.57 | $258k | | 09/15/2021 |
07/15/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 10k | $20.90 | $209k | | 07/15/2021 |
12/08/2020 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 77.6k | $28.35 | $2.2M | | 12/08/2020 |
06/30/2020 | Akero Therapeutics, Inc. | AKRO | Grant | Common Stock | 1.2k | $17.07 | $21.2k | | 12/08/2020 |
12/31/2019 | Akero Therapeutics, Inc. | AKRO | Grant | Common Stock | 1k | $18.87 | $19.3k | | 12/31/2019 |
12/13/2019 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 85k | $21.09 | $1.8M | | 12/13/2019 |
|